… of financings in the biotech arena this week is led … a bisphosphonate drug marketed in Italy by Abiogen Pharma for CRPS- … clinical trials of its lead drugs for inherited blood disorder … , Berkeley, California startup Aeovian Pharma added $55 million to its …

… developed to a U.S. biotech company. The company announced on … -the-counter drugs (OTC) or generic and biosimilar segments, domestic pharmaceutical companies … -off ranks by establishing new drug development company Acella in October …

… company aims to discover innovative drug discovery seeds and to … nervous system diseases and generic drugs. To further address unmet … INDUSTRY KEYWORD: SCIENCE NEUROLOGY BIOTECHNOLOGY RESEARCH PHARMACEUTICAL HEALTH INFECTIOUS DISEASES HEALTH TECHNOLOGY …

… reinventing the very act of pharmaceutical research. Across leading biopharma … in drug discovery, benchmark-to-value gap, biological complexity, biotech hiring … longitudinal memory, Machine Learning in Pharma, pharmaceutical R&D, primary intelligence …

… the award clearly demonstrated that biotechnology is no longer the future … special attention to achievements in pharmaceuticals and drug development. Companies whose innovations … the development of medical and biotechnological projects within the framework of …

… pharmaceutical innovation hub, shifting from a copycat drug … development capabilities rival global pharmaceutical behemoths, according to … consultancy released the China Pharmaceutical Innovation and Invention Index … of early-stage biotech companies in China …

… NxWave™ structure-based drug design platform to improve … daily dosing. Notably, pharmacodynamic endpoints including cognitive assessments … END– About Nxera Pharma Nxera Pharma is a technology … partnership with leading pharma and biotech companies. This pipeline …

… , intravesical delivery limits drug contact and penetration, … UroGen Pharma) and gemcitabine intravesical system (Inlexzo; Janssen Biotech).8 … decisions. As experts in medication management, they must … /drugs/resources-information-approved-drugs/ …

… first appeared in Adam’s Biotech Scorecard, a subscriber-only … last, edition of the Biotech Scorecard newsletter in 2025.  By … Adobe The old saw: Biotech will never attract a … saw: Development-stage biotechs are maturing. Their drugs are winning approvals …

… DeAngelis is the East Coast biotech and venture capital reporter at … dropping coverage of weight loss drugs? And what will the hosts … drop coverage of weight loss drugs. To read more on Adam … dropping coverage of weight loss drugs, go here. Be sure to …